台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

PD02-5: Intracavernous injection of autologous platelet-rich plasma ameliorated hyperlipidemia-associated erectile dysfunction in a rat model

2021-05-20 • 觀看: 1565 • 回應: 0 • doc
PD02-4: Predictive factors for sperm retrieval rate from male with non-obstructive azoospermia

2021-05-20 • 觀看: 1475 • 回應: 0 • doc
PD02-3: Assisted reproductive technology outcome in patients with ejaculatory dysfunction using EEJ or needle-TESE

2021-05-20 • 觀看: 1545 • 回應: 0 • doc
PD02-2: MAEL gene expression in testes and ejaculated sperms of infertile men

2021-05-20 • 觀看: 1646 • 回應: 0 • doc
PD02-1: Fatty liver index is associated with the risk of testosterone deficiency in aging men without metabolic syndrome

2021-05-20 • 觀看: 1740 • 回應: 0 • doc
PD01-6: Development of a nomogram with combined prostate health index and multiparametric magnetic resonance imaging for predicting extracapsular extension in radical prostatectomy specimens

2021-05-20 • 觀看: 1614 • 回應: 0 • doc
PD01-5: MicroRNA-107 enhances radiosensitivity by suppressing granulin in PC-3 prostate cancer cells

2021-05-20 • 觀看: 1510 • 回應: 0 • doc
PD01-4: Delayed foley catheter removal after robotic assisted laparoscopic prostatectomy

2021-05-20 • 觀看: 1586 • 回應: 0 • doc
PD01-3: Association of human polyomavirus, JC and BK virus, infection with prostate cancer in Taiwan

2021-05-20 • 觀看: 1732 • 回應: 0 • doc
PD01-2: Pelvic Lymph Node Dissection Using Indocyanine Green Fluorescence Lymphangiography in Robotic Assisted Radical Prostatectomy for Non-lymph Node or Distant Metastasis Prostate Cancer Patients.

2021-05-20 • 觀看: 1743 • 回應: 0 • doc
PD01-1: Safety of darolutamide (DARO) for non-metastatic castration-resistant prostate cancer (nmCRPC) from extended follow-up in the phase III ARAMIS trial

2021-05-20 • 觀看: 1594 • 回應: 0 • doc
(VS-4) Robotic-assisted bladder neck sparing prostatectomy after neoadjuvant hormone therapy for a high risk patient_楊涵中

2021-04-28 • 觀看: 246 • 回應: 0 • 影片

Prev
694
695
696
697
698
699
700
701
702
703
Next
/ 1262